Use of genetically engineered pancreatic β cells in the treatment of experimentally induced diabetes

R. Stein, B. A. Hicks, A. A. Demetriou

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Scopus citations
Original languageEnglish (US)
Title of host publicationXenograft 25
Subtitle of host publicationproceedings of the International Congress, Xenograft 25. ICS880
EditorsM.A. Hardy
PublisherElsevier Science Publishers B.V.
Pages309-317
Number of pages9
ISBN (Print)0444811133, 9780444811134
StatePublished - Jan 1 1989
EventThe International Congress, Xenograft 25 - Harriman, N.Y., UNITED S
Duration: Nov 11 1988Nov 13 1988

Conference

ConferenceThe International Congress, Xenograft 25
CityHarriman, N.Y., UNITED S
Period11/11/8811/13/88

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Stein, R., Hicks, B. A., & Demetriou, A. A. (1989). Use of genetically engineered pancreatic β cells in the treatment of experimentally induced diabetes. In M. A. Hardy (Ed.), Xenograft 25: proceedings of the International Congress, Xenograft 25. ICS880 (pp. 309-317). Elsevier Science Publishers B.V..